Cardiovascular, Diabetes, Endocrinology
Stroke and Diabetes: Guidelines and Key Considerations
People living with diabetes are at a higher risk for stroke than those without diabetes. Recent evidence shows that certain drugs have demonstrated an ability to reduce the risk of stroke in individuals with type 2 diabetes.
This module will review data from cardiovascular outcome trials and meta-analyses, along with the recommendations from 2019 ESC guidelines, for optimizing cardiovascular care in this population.
DURATION
1 hr
PROFESSION
Specialist
# OF CREDITS
1
ACCREDITATION
EACCME
EXPIRY DATE
2024-03-20
People living with diabetes are at a higher risk for stroke than those without diabetes. Recent evidence shows that certain drugs have demonstrated an ability to reduce the risk of stroke in individuals with type 2 diabetes.
This module will review data from cardiovascular outcome trials and meta-analyses, along with the recommendations from 2019 ESC guidelines, for optimizing cardiovascular care in this population.
This program has received an unrestricted educational grant or in-kind support from Novo Nordisk A/S.
Faculty
David Strain, BSc, MB. ChB., MRCP, MD, FRCP
Matthias Bluher, MD
Learning objectives
Upon successful completion of this continuing education module, the participant will be better able to:
- Describe the risk of stroke in patients with diabetes
- Summarize the evidence for different antihyperglycemic agents on stroke reduction
- Discuss the guidelines recommendations from the 2019 ESC guidelines for cardiovascular protection in people with diabetes
- Adjust a patient’s diabetes regimen to provide cardiovascular protection, according to 2019 ESC guidelines
Accreditation
Accreditation number: ELM23-A00009.